Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Photo of John Carey
Person

John Carey

Overview

Edit Overview Section
CB Rank (Person) 578,032
  • Primary Job Title Vice President of Operations
  • Primary Organization 
    TransMedics Logo
    TransMedics
John Carey is the Vice President of Operations at Transmedics.

Jobs

Edit Jobs Section
Number of Current Jobs 1
Number of Past Jobs 1
John Carey is the Vice President of Operations at TransMedics. Additionally, John Carey has had 1 past job as the AME Section Head at C. R. Bard.
Organization Name  
Title At Company  
Start Date  
End Date  
C. R. Bard Logo
C. R. Bard
AME Section Head19911997

Related Hubs

Edit Related Hubs Section
Hub Name  
CB Rank (Hub)  
Greater Boston Area Medical Companies Logo
Greater Boston Area Medical Companies
27,514
Greater Boston Area Public Companies Logo
Greater Boston Area Public Companies
50,173
Service Industry Public Companies With Fewer Than 1000 Employees Logo
Service Industry Public Companies With Fewer Than 1000 Employees
72,428
Medical Device Public Companies Logo
Medical Device Public Companies
37,979
Northeastern US Service Industry Companies Logo
Northeastern US Service Industry Companies
11,866
Medical Device Public Companies With More Than $100M in Revenue Logo
Medical Device Public Companies With More Than $100M in Revenue
75,179
Medical Device Public Companies With Less Than $1B in Revenue Logo
Medical Device Public Companies With Less Than $1B in Revenue
55,486
Tudor Investments Portfolio Companies Logo
Tudor Investments Portfolio Companies
98,744
CB Health Ventures Portfolio Companies Logo
CB Health Ventures Portfolio Companies
96,392
Massachusetts Service Industry Companies Logo
Massachusetts Service Industry Companies
54,496

Education

Edit Education Section
John Carey studied at Dartmouth College.

Recent News and Activity

Edit Recent News and Activity Section
Number of News Articles 12
News•Jun 10, 2021
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 8, 2021
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Sep 22, 2020
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 9, 2020
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 27, 2018
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 12, 2018
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 12, 2018
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 11, 2018
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 11, 2018
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 19, 2018
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
View All
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(05b78c5 1)
|